Introducing the Coforix Clinical and Safety Advisory Board

Today we proudly announce the formation of Coforix’s Clinical and Safety Advisory Board: a diverse group of thought leaders who will guide our clinical strategy and ensure that safety remains at the forefront of our innovations.

“Generative AI holds immense potential for the future of healthcare, and Coforix is at the forefront of this innovation. From the very beginning, clinical relevance, safety, and a responsible approach to this powerful technology have been core principles in our work. Therefore, I’m delighted to have the opportunity to work with such esteemed experts in the field who will advise us on these crucial topics.”

— Marcel Alberti, CEO & Co-founder, Coforix

A wealth of experience and unique perspectives

Coforix is committed to addressing the most pressing challenges in healthcare today, by developing advanced AI solutions to simplify complex data management. We know that safety, trust, and clinical excellence are crucial to achieve our goals. That is why we have formed our Clinical and Safety Advisory Board, consisting of four highly respected clinical experts from three European countries, each bringing a wealth of experience and unique perspectives to the table.

Focus areas

The Clinical and Safety Advisory Board will focus on two critical areas: clinical strategy and safety. In terms of clinical strategy, these experts will help us prioritize the most impactful AI solutions, drawing from emerging trends in healthcare and their collective expertise.

Safety is the second key pillar of the board’s work. The board will provide insights to ensure our models and applications meet the highest safety standards. Furthermore, the board will evaluate the risk profiles of different use cases and advise us accordingly, ensuring our technology remains safe and trustworthy for both patients and healthcare professionals.

Additionally, the Clinical and Safety Advisory Board will serve as a platform for feedback and open discussions, allowing for new ideas and improvements. This level of transparency and input ensures that we’re always proactive in our approach to healthcare innovation.

“It is an honor to participate in the Clinical and Safety Advisory Board of Coforix. While generative AI could be a game changer in the healthcare industry, it is of paramount importance to focus its power on the relevant topics, with the safety of patients and the integrity of hospitals in mind. With my colleagues on the board we will support the company’s vision to provide valuable and responsible solutions to its customers — being doctors, healthcare administrators, or third-party developers of healthcare-related software applications.”

— Jan Kimpen, Chair of the Clinical & Safety Advisory Board

State-of-the-art solutions

With the formation of the Clinical and Safety Advisory Board, we are reinforcing our dedication to developing state-of-the-art AI solutions while maintaining the highest levels of safety and clinical integrity. This collaboration with leading experts allows us to continuously evolve and ensure that our products meet the high demands of the healthcare sector.